ModernMedicine Resource Center More Topics


FDA Assists Generic Drugmakers with New GuidancesThe FDA is promoting generic competition and issuing new REMS guidance.
Multistate Generic Lawsuit Expands and Includes ExecutivesA multistate antitrust investigation into generic drug pricing has expanded further.
Report: Medicare Biosimilar Changes Could Save BillionsA change in reimbursement policy for biosimilar drugs could save CMS billions.
FDA Promises Easier Generic Drug ApplicationsThe FDA has issued draft guidances that should ease the way for more generic drugs.
Law Reauthorizes FDA Fees and Increases Access to Generics/BiosimilarsSenate passes FDARA overwhelmingly, ahead of September deadline.
Gottlieb Pushes for Generic Drug AccessBrand name drug companies are "gaming" the system, according to the FDA head.
Generic Cholesterol Meds a Boon for PatientsTwo recent generic cholesterol-lowering drugs are helping reduce health-care costs.
Priority Generic Drugs to Get Faster FDA ReviewFDA will shorten the review periods for priority generic drugs by two months.
Supreme Court Ruling Raises Biosimilars’ AccessHigh court ruling should make biosimilars available faster.
AAM Report on Generics Finds High Brand Abandonment RatePatients are less like to buy a requested brand name prescription than a generic one.